MAPT and Alzheimer disease: Endpoints included intact fatty acid profiles, oxidized fatty acid (isoprostanes) profiles, prostaglandins, as well as the extent of Aβ, tau, and synaptic pathologies in the brain cortex of 3xTg-AD mice.